Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1812020200260040505
Journal of Neurogastroenterology and Motility
2020 Volume.26 No. 4 p.505 ~ p.513
Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea
Lu Jia

Shi Lili
Huang Dan
Fan Wenjuan
Li Xiaoqing
Zhu Liming
Wei Jing
Fang Xiucai
Abstract
Background/Aims: A strong correlation between depression and irritable bowel syndrome with diarrhea (IBS-D) has been identified. The aim of this study is to identify the correlations among depression, structural factors, gastrointestinal (GI) and extra-GI symptoms, and efficacy of neuromodulators in patients with IBS-D.

Methods: Patients meeting the Rome III Diagnostic Criteria for IBS-D were enrolled. The intestinal symptoms and psychological states were evaluated using IBS-specific symptom questionnaires and Hamilton Depression Rating Scale.

Results: In total, 410 patients with IBS-D were enrolled, 28.8% (118/410) had comorbid depression. Patients with depression did not readily experience improvement in abdominal pain/discomfort after defecation, and had a higher prevalence of passing mucus, overlapping functional dyspepsia, and extra-GI symptoms. The structural factor ¡°mental disorders¡± significantly correlated with main bowel symptom score and degree of pre-defecation abdominal pain/discomfort. No structural factor significantly correlated with bowel movements or stool form. Patients who had passing mucus, overlapping functional dyspepsia and extra-GI painful symptoms have higher score of ¡°anxiety/somatization.¡± Patients with sexual dysfunction have higher score of ¡°retardation symptoms.¡± In total, 28.3% of patients with IBS-D were prescribed neuromodulators. Baseline scores of ¡°anxiety/somatization¡± and ¡°retardation symptoms¡± positively correlated with improvement of diarrhea after paroxetine, and ¡°sleep disturbances¡± positively correlated with improvement of abdominal pain/discomfort and diarrhea after mirtazapine.

Conclusions: Comorbid depression and higher scores of structural factors might aggravate GI and extra-GI symptoms other than bowel movements and stool form. Structural factors of Hamilton Depression Rating Scale correlated with efficacy of paroxetine and mirtazapine in patients with IBS-D.
KEYWORD
Depression, Irritable bowel syndrome, Neuromodulators
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø